Dr. Anthony Komaroff of Harvard got a great editorial in a top journal - the Annals of Internal Medicine...\\
Following up on the release of the P2P and IOM reports Komaroff hit the readers of the Annals with some hard facts:
The IOM estimates that 836 000 to 2.5 million Americans have ME/CFS (5).
The direct and indirect economic costs of the illness to society are estimated to be between $17 billion and $24 billion annually.
Komaroff quashed persistent reports that ME/CFS is a symptom-based illness stating
Simply restating what the reports said was more than enough:
Komaroff ends with this powerful paragraph:
Following up on the release of the P2P and IOM reports Komaroff hit the readers of the Annals with some hard facts:
The IOM estimates that 836 000 to 2.5 million Americans have ME/CFS (5).
The direct and indirect economic costs of the illness to society are estimated to be between $17 billion and $24 billion annually.
Komaroff quashed persistent reports that ME/CFS is a symptom-based illness stating
According to the most widely used case definition (6), the illness is characterized exclusively by symptoms; therefore, physicians have understandably wondered whether there are "real" underlying biological abnormalities. The IOM, AHRQ, and NIH panels concluded that there are such biological abnormalities
Simply restating what the reports said was more than enough:
After evaluating thousands of published articles, the IOM committee stated that "ME/CFS is a serious, chronic, complex systemic disease that often can profoundly affect the lives of patients" (5). Summarizing the committee's deliberations, Ganiats (1) said that the illness "is not, as many clinicians believe, a psychological problem," while emphasizing that psychiatric comorbid conditions occur in some patients with ME/CFS and need to be diagnosed and treated.
Komaroff ends with this powerful paragraph:
These reports from the IOM, AHRQ, and NIH demonstrate how much we have learned about ME/CFS and how much we still do not know. We do not understand its pathogenesis, and we do not have a diagnostic test or a cure. However, these recent reports, summarizing information from more than 9000 articles, should put the question of whether ME/CFS is a "real" illness to rest. When skeptical physicians, many of whom are unaware of this literature, tell patients with ME/CFS that "there is nothing wrong," they not only commit a diagnostic error: They also compound the patients' suffering.